| Primary |
| Osteoporosis |
51.6% |
| Osteopenia |
19.5% |
| Hypertension |
5.0% |
| Osteoporosis Prophylaxis |
4.3% |
| Rheumatoid Arthritis |
2.7% |
| Hypothyroidism |
1.8% |
| Asthma |
1.6% |
| Depression |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Prophylaxis |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Diabetes Mellitus |
1.2% |
| Pain |
1.1% |
| Hypersensitivity |
1.0% |
| Hormone Replacement Therapy |
0.9% |
| Anxiety |
0.9% |
| Arthritis |
0.8% |
| Blood Pressure |
0.8% |
| Osteoarthritis |
0.8% |
| Bone Density Decreased |
0.8% |
|
| Femur Fracture |
25.4% |
| Osteonecrosis |
19.0% |
| Low Turnover Osteopathy |
6.1% |
| Weight Decreased |
6.0% |
| Death |
4.6% |
| Stress Fracture |
3.8% |
| Tooth Disorder |
3.5% |
| Urinary Tract Infection |
3.4% |
| Vomiting |
3.2% |
| Wrist Fracture |
3.1% |
| Tooth Loss |
2.9% |
| Weight Increased |
2.7% |
| Vitamin D Deficiency |
2.6% |
| Osteoporosis |
2.3% |
| Osteonecrosis Of Jaw |
2.2% |
| Tooth Fracture |
2.2% |
| Pain In Extremity |
2.0% |
| Fall |
2.0% |
| Osteomyelitis |
1.8% |
| Drug Ineffective |
1.4% |
|
| Secondary |
| Osteoporosis |
45.9% |
| Osteopenia |
25.7% |
| Osteoporosis Prophylaxis |
5.7% |
| Hypertension |
3.7% |
| Rheumatoid Arthritis |
2.7% |
| Hypothyroidism |
1.8% |
| Prophylaxis |
1.3% |
| Asthma |
1.3% |
| Blood Pressure |
1.2% |
| Depression |
1.2% |
| Product Used For Unknown Indication |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Hypersensitivity |
1.0% |
| Blood Cholesterol Increased |
1.0% |
| Hormone Replacement Therapy |
1.0% |
| Diabetes Mellitus |
0.9% |
| Pain |
0.8% |
| Bone Density Decreased |
0.8% |
| Osteoarthritis |
0.8% |
| Arthritis |
0.8% |
|
| Femur Fracture |
16.2% |
| Low Turnover Osteopathy |
10.7% |
| Weight Decreased |
10.1% |
| Weight Increased |
6.6% |
| Wrist Fracture |
6.4% |
| Urinary Tract Infection |
6.2% |
| Vitamin D Deficiency |
5.7% |
| Vomiting |
5.1% |
| Stress Fracture |
4.9% |
| Tooth Disorder |
3.9% |
| Tooth Fracture |
2.9% |
| Osteoporosis |
2.8% |
| Upper Respiratory Tract Infection |
2.5% |
| Tooth Loss |
2.5% |
| Vertigo |
2.5% |
| Anxiety |
2.5% |
| Fall |
2.5% |
| Osteonecrosis |
2.2% |
| Blood Cholesterol Increased |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.3% |
| Drug Use For Unknown Indication |
18.4% |
| Rheumatoid Arthritis |
12.4% |
| Osteoporosis |
9.7% |
| Hypertension |
5.9% |
| Pain |
3.7% |
| Hormone Replacement Therapy |
2.8% |
| Depression |
2.4% |
| Blood Cholesterol Increased |
2.3% |
| Asthma |
2.3% |
| Multiple Sclerosis |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Crohn's Disease |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Prophylaxis |
1.6% |
| Arthritis |
1.5% |
| Breast Cancer |
1.5% |
| Diabetes Mellitus |
1.4% |
| Atrial Fibrillation |
1.3% |
| Insomnia |
1.3% |
|
| Weight Decreased |
12.1% |
| Vomiting |
11.6% |
| Weight Increased |
7.3% |
| Nausea |
6.2% |
| Pneumonia |
5.1% |
| Urinary Tract Infection |
5.1% |
| Death |
5.0% |
| Drug Ineffective |
4.8% |
| Pain |
4.4% |
| Myocardial Infarction |
4.3% |
| Vision Blurred |
4.3% |
| Rash |
3.8% |
| Pain In Extremity |
3.7% |
| Somnolence |
3.7% |
| Dyspnoea |
3.6% |
| Breast Cancer |
3.4% |
| Pyrexia |
3.2% |
| Tremor |
3.0% |
| Breast Cancer Female |
2.7% |
| Oedema Peripheral |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
35.1% |
| Product Used For Unknown Indication |
16.5% |
| Arrhythmia |
6.2% |
| Blood Pressure |
6.2% |
| Bone Disorder |
6.2% |
| Pain |
4.1% |
| Antibiotic Therapy |
3.1% |
| Anticoagulant Therapy |
3.1% |
| Back Pain |
3.1% |
| Convulsion |
3.1% |
| Steroid Therapy |
3.1% |
| Glomerulonephritis |
2.1% |
| Alopecia |
1.0% |
| Anxiety |
1.0% |
| Atrial Fibrillation |
1.0% |
| Blood Cholesterol Increased |
1.0% |
| Bone Density Decreased |
1.0% |
| Erectile Dysfunction |
1.0% |
| Fluid Retention |
1.0% |
| Heart Rate Irregular |
1.0% |
|
| Drug Interaction |
21.1% |
| Hepatic Enzyme Increased |
15.8% |
| Weight Decreased |
15.8% |
| Drug Ineffective |
5.3% |
| Gastroenteritis |
5.3% |
| International Normalised Ratio Decreased |
5.3% |
| Melaena |
5.3% |
| Musculoskeletal Pain |
5.3% |
| Rash Generalised |
5.3% |
| Somnolence |
5.3% |
| Spinal Compression Fracture |
5.3% |
| Tremor |
5.3% |
|
